Hep C Drug Boceprevir is Faster and Better
FDA says Merck hepatitis drug a faster cure
April 26, 2011 | By David Sell, Inquirer Staff Writer
Merck researchers in North Wales and Kenilworth, N.J., received some tentative but good news Monday when Food and Drug Administration staff members reported that Merck’s drug to fight the hepatitis C virus cured most patients faster and more completely than older medications during clinical trials.
Continue reading this entire article:
Idera's Hep C Drug Put on Hold
FDA Backs Telaprevir for Having High Hepatitis C Cure Rate